[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 172
Citations 0
Comment & Response
January 2017

Surgical Treatment for T4 Oropharyngeal Cancer

Author Affiliations
  • 1The University of Texas MD Anderson Cancer Center, Houston
JAMA Otolaryngol Head Neck Surg. 2017;143(1):96-97. doi:10.1001/jamaoto.2016.2242

To the Editor The article by Zenga et al1 on the role of surgery for T4 oropharyngeal cancer was interesting, but I believe it had several omissions that add to the limitations. The most problematic issue with the analysis was the inherent bias in a comparison between 2 groups, 1 that undergoes the therapy (surgery) and 1 that does not, when the latter group has patients who either medically or technically cannot receive the therapy.

First Page Preview View Large
First page PDF preview
First page PDF preview